Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DnaJ heat shock protein family (Hsp40) consists of a large group of molecular chaperones defined by a conserved J-domain that interacts with Hsp70 [10, 11]. These proteins are essential for cellular proteostasis, assisting in protein folding, assembly, and the prevention of toxic aggregation by stimulating the ATPase activity of Hsp70 [1, 10]. In oncology, various Hsp40 members are frequently overexpressed, where they stabilize oncoproteins and promote tumor cell survival and chemoresistance [2, 12]. Conversely, in neurodegenerative diseases like Parkinson's and Alzheimer's, Hsp40 proteins play a protective role by preventing the accumulation of misfolded protein aggregates [7, 11]. Therapeutic development focuses on small-molecule inhibitors to target specific Hsp40 isoforms in cancer or activators to enhance their chaperone function in neurodegeneration [2, 11]. For instance, DNAJA1 has been identified as a potential target for anti-tumor therapy due to its role in stabilizing mutant p53 [2]. However, the high degree of homology among the 41 human family members presents significant challenges for achieving selectivity and avoiding systemic toxicity [10, 15]. Despite these challenges, Hsp40 remains a promising target for precision medicine given its specific roles in various disease pathologies [6, 13].
Stimulation of Hsp70 ATPase activity to facilitate protein folding and prevent aggregation; therapeutic inhibitors block this interaction to destabilize oncoproteins in cancer.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) (Hsp40).